RNN IMO is very undervalued. Its one of the few biotech stocks out there that has yet to run. They have a very nice pipeline, No debt and decent cash on hand. Right now they have two drugs in stage 2 trials and 1 or two drugs in stage 1. I think when this one finally gets hot its going to move very nice to be honest.
Market Data 
Markets 
AI
